Combination of alpha blocker and phosphodiesterase 5 inhibitors versus alpha blocker monotherapy for lower urinary tract symptoms associated with benign prostate hyperplasia: A systematic review and meta-analysis

2019 ◽  
Vol 18 (1) ◽  
pp. e1990-e1991
Author(s):  
P-C. Chen ◽  
T-C. Yeh
Sign in / Sign up

Export Citation Format

Share Document